Camargo Pharmaceutical Services names chief operating officer
November 25, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Camargo Pharmaceutical Services
Veteran healthcare executive Jim Beach has been named chief operating officer for drug development firm Camargo Pharmaceutical Services. “Jim’s history …
Gilead gets CHMP nod
November 25, 2013Research and Development, Sales and Marketing CHMP, FDA, Gilead, chc, sovaldi
The CHMP has opened the way for Gilead Sciences’ first-in-class investigational chronic hepatitis C drug Sovaldi (sofosbuvir) to get to …
E-prescribing ‘patchy at best’
November 22, 2013Medical Communications, Sales and Marketing DoH, NHS, UCL, e-prescribing
Electronic prescribing in NHS hospitals – seen as one of the cornerstones of public health provision in the future – …
Cancer app takes top prize in Janssen digital awards
November 22, 2013Medical Communications, Sales and Marketing Cancer, J&J, JJ, app, digital, px healthcare
A start-up firm established by medical scientists that develops mobile apps for cancer patients has taken first place in the …
Big data ‘road map’ launched by ABPI
November 22, 2013Medical Communications, Research and Development, Sales and Marketing ABPI, BMA, NIHR, data, transparency
The ABPI has launched a new initiative that aims to harness the potential of big data to improve patient care …
Life makes several changes
November 22, 2013Medical Communications, Research and Development, Sales and Marketing Life, comms, creative, healthcare
Marketing communications firm Life is restructuring to advance its status as an integrated creative company. As part of this process …
Coalition launches rare disease strategy
November 22, 2013Research and Development, Sales and Marketing DoH, NHS, R&D, rare disease
The Department of Health has launched the UK’s first strategy on rare diseases as part of a bid to boost …
Lilly signs Lou Gehrig’s disease deal
November 21, 2013Research and Development, Sales and Marketing als, hill, lilly, lou gehrig
Eli Lilly & Company has signed a deal with US charity Project A.L.S. to find new treatments for the debilitating …
GSK makes £425 million Aspen sale
November 21, 2013Sales and Marketing GSK, Merck, South Africa, aspen
GlaxoSmithKline has raised £425 million with the sale of 28.2 million shares that it has in Africa’s biggest drugmaker as …
Smartphone app to aid brain injury sufferers
November 21, 2013Medical Communications brain, brain in hand, digital, glenside, smartphone, wells
Neurological rehabilitation firm Glenside are running a large-scale pilot which uses smartphone technology to improve the lives of people with …
NHS responds to Mid Staffs
November 21, 2013Sales and Marketing Francis, Mid Staffs, NHS, UK
The government has accepted 281 out of the 290 recommendations contained in the Francis report – the damning document published …
Novasep appoints president of Industrial Biotech business
November 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novasep
French processing equipment supplier Novasep has appointed Nadege Laborde as the new president of its Industrial Biotech business unit. It …
Global prescriptions cost to hit $1 trillion
November 20, 2013Medical Communications, Research and Development, Sales and Marketing IMS, UK, prescriptions
The worldwide cost of medicine prescriptions will for the first time hit $1 trillion next year as drugs get more …
EMA looks to sharpen HTA data output
November 20, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EMA, NICE, hta, transparency
The European Medicines Agency (EMA) has deepened its partnership with the European network for Health Technology Assessment (EUnetHTA) as it …
Healthcare UK appoints medical director
November 20, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, healthcare uk
Professor Rory Shaw has been hired as the medical director of Healthcare UK to lead the newly-established NHS International Development …
AstraZeneca sells arthritis drug for $35 million
November 20, 2013Sales and Marketing AstraZeneca, RA, arthritis, horizon, vimovo
AstraZeneca has sold rights to its arthritis treatment Vimovo to speciality pharma firm Horizon Pharma for $35 million. AZ retains …
Understanding Which Types of Design Should Be Driving Innovation at Drug Delivery Device Suppliers
November 20, 2013Manufacturing and Production auto injector, autoinjector, autoinjector innovation, shl autoinjector
SHL’s recent article “Understanding Which Types of Design Should Be Driving Innovation at Drug Delivery Device Suppliers” was featured in …
SHL introduces new mobile website
November 20, 2013Manufacturing and Production shl group, shl mobile, shl social media
SHL recently introduced a mobile website which allows mobile device users to view the company’s corporate website in a more …
Pfizer launches another ‘medicine optimisation’ campaign
November 19, 2013Medical Communications Pfizer, RPS, npa, treatments
Patients would be more likely to follow prescriptions if they had better knowledge about the drugs they were taking according …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
